This study suggested that QHTTF treatment may regulate insulin resistance by upregulating IRS-1 and GLUT4 expression in pancreatic tissues, potentially indicating modulation of the insulin signaling pathway. The gene discussed is SLC2A4; the disease is Insulin resistance.